1
|
Lima G, Shurlock J, Wang G, Karanikolou A, Sutehall S, Pitsiladis YP, D'Alessandro A. Metabolomic Profiling of Recombinant Erythropoietin (rHuEpo) in Trained Caucasian Athletes. Clin J Sport Med 2023; 33:e123-e134. [PMID: 36731031 DOI: 10.1097/jsm.0000000000001074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2021] [Accepted: 01/03/2022] [Indexed: 02/04/2023]
Abstract
OBJECTIVE Recombinant human erythropoietin (rHuEpo) is prohibited by the World Anti-Doping Agency but remains the drug of choice for many cheating athletes wishing to evade detection using current methods. The aim of this study was to identify a robust metabolomics signature of rHuEpo using an untargeted approach in blood (plasma and serum) and urine. DESIGN Longitudinal study. SETTING University of Glasgow. PARTICIPANTS Eighteen male participants regularly engaged in predominantly endurance-based activities, such as running, cycling, swimming, triathlon, and team sports, were recruited. INTERVENTIONS Each participant received 50 IU·kg -1 body mass of rHuEpo subcutaneously every 2 days for 4 weeks. Samples were collected at baseline, during rHuEpo administration (over 4 weeks) and after rHuEpo administration (week 7-10). The samples were analyzed using hydrophilic interaction liquid chromatography mass spectrometry. MAIN OUTCOME MEASURES Significant metabolic signatures of rHuEpo administration were identified in all biofluids tested in this study. RESULTS Regarding metabolomics data, 488 plasma metabolites, 694 serum metabolites, and 1628 urinary metabolites were identified. Reproducible signatures of rHuEpo administration across all biofluids included alterations of pyrimidine metabolism (orotate and dihydroorotate) and acyl-carnitines (palmitoyl-carnitine and elaidic carnitine), metabolic pathways that are associated with erythropoiesis or erythrocyte membrane function, respectively. CONCLUSIONS Preliminary metabolic signatures of rHuEpo administration were identified. Future studies will be required to validate these encouraging results in independent cohorts and with orthogonal techniques, such as integration of our data with signatures derived from other "omics" analyses of rHuEpo administration (eg, transcriptomics).
Collapse
Affiliation(s)
- Giscard Lima
- School of Sport and Health Sciences, University of Brighton, Brighton, United Kingdom
- University of Rome "Foro Italico," Rome, Italy
| | - Jonathan Shurlock
- School of Sport and Health Sciences, University of Brighton, Brighton, United Kingdom
| | - Guan Wang
- Sport and Exercise Science and Sports Medicine Research and Enterprise Group, University of Brighton, Brighton, United Kingdom
| | - Antonia Karanikolou
- School of Sport and Health Sciences, University of Brighton, Brighton, United Kingdom
| | - Shaun Sutehall
- Division of Physiological Sciences, Department of Human Biology, University of Cape Town, Cape Town, South Africa
| | - Yannis P Pitsiladis
- School of Sport and Health Sciences, University of Brighton, Brighton, United Kingdom
- Centre for Exercise Sciences and Sports Medicine, FIMS Collaborating Centre of Sports Medicine, Rome, Italy
- European Federation of Sports Medicine Associations (EFSMA), Lausanne, Switzerland
- International Federation of Sports Medicine (FIMS), Lausanne, Switzerland; and
| | - Angelo D'Alessandro
- Department of Biochemistry and Molecular Genetics, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado
| |
Collapse
|
2
|
Cloteau C, Dervilly G, Loup B, Delcourt V, Kaabia Z, Bagilet F, Groseille G, Dauriac K, Fisher S, Popot MA, Garcia P, Le Bizec B, Bailly-Chouriberry L. Performance assessment of an equine metabolomics model for screening a range of anabolic agents. Metabolomics 2023; 19:38. [PMID: 37027080 DOI: 10.1007/s11306-023-01985-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Accepted: 03/04/2023] [Indexed: 04/08/2023]
Abstract
INTRODUCTION Despite their ban, Anabolic Androgenic Steroids (AAS) are considered as the most important threat for equine doping purposes. In the context of controlling such practices in horse racing, metabolomics has emerged as a promising alternative strategy to study the effect of a substance on metabolism and to discover new relevant biomarkers of effect. Based on the monitoring of 4 metabolomics derived candidate biomarkers in urine, a prediction model to screen for testosterone esters abuse was previously developed. The present work focuses on assessing the robustness of the associated method and define its scope of application. MATERIALS AND METHODS Several hundred urine samples were selected from 14 different horses of ethically approved administration studies involving various doping agents' (AAS, SARMS, β-agonists, SAID, NSAID) (328 urine samples). In addition, 553 urine samples from untreated horses of doping control population were included in the study. Samples were characterized with the previously described LC-HRMS/MS method, with the objective of assessing both its biological and analytical robustness. RESULTS The study concluded that the measurement of the 4 biomarkers involved in the model was fit for purpose. Further, the classification model confirmed its effectiveness in screening for testosterone esters use; and it demonstrated its ability to screen for the misuse of other anabolic agents, allowing the development of a global screening tool dedicated to this class of substances. Finally, the results were compared to a direct screening method targeting anabolic agents demonstrating complementary performances of traditional and omics approaches in the screening of anabolic agents in horses.
Collapse
Affiliation(s)
- C Cloteau
- LABERCA, ONIRIS, INRAE, 44300, Nantes, France.
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France.
| | - G Dervilly
- LABERCA, ONIRIS, INRAE, 44300, Nantes, France
| | - B Loup
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - V Delcourt
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - Z Kaabia
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - F Bagilet
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - G Groseille
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - K Dauriac
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - S Fisher
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - M A Popot
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - P Garcia
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| | - B Le Bizec
- LABERCA, ONIRIS, INRAE, 44300, Nantes, France
| | - L Bailly-Chouriberry
- Laboratoire des Courses Hippiques (GIE-LCH), 91370, Verrières Le Buisson, France
| |
Collapse
|
3
|
Lauritzen F, Holden G. Intelligence-based doping control planning improves testing effectiveness: Perspectives from a national anti-doping organisation. Drug Test Anal 2022; 15:506-515. [PMID: 36582051 DOI: 10.1002/dta.3435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2022] [Revised: 12/22/2022] [Accepted: 12/27/2022] [Indexed: 12/31/2022]
Abstract
Anti-doping organisations are mandated to provide a comprehensive anti-doping programme, which aims to detect, deter and prevent doping in sport. Direct detection of prohibited substances and methods by collection of biological samples from athletes makes up about half of the global anti-doping budgets but has in the last decade been under critical scrutiny for its lack of efficiency. To ensure optimum detection and deterrence of testing and prevention efforts, a better understanding of doping practices and comparison of different doping test strategies are needed. This study evaluates 17 years of doping test statistics and Anti-Doping Rule Violations (ADRVs) from the perspectives of a national anti-doping organisation. A total of 48 709 samples (2865 ± 220 annually) were collected by Anti-Doping Norway in the period 2003-2019, which resulted in total 216 ADRVs (12.7 ± 3.7 annually), providing an average sample-to-ADRV rate of 0.44% when including urine, blood and ABP samples. Most athletes who committed ADRVs were men participating in ball and team or strength sports at a national or recreational level. Few ADRVs were recorded among elite athletes and in most high-risk sports, despite these groups being subjected to the highest number of doping tests. The number of annual ADRVs did not correlate with the corresponding number of collected doping samples. However, systematic use of intelligence in the test planning process was associated with an increase in ADRVs. Anti-doping organisations would benefit from improving their target testing capability and to take an intelligence-led approach in planning doping tests.
Collapse
Affiliation(s)
| | - Geir Holden
- Department of Testing, Investigations and Legal, Anti-Doping Norway, Oslo, Norway
| |
Collapse
|
4
|
Gholami MD, Theiss F, Sonar P, Ayoko GA, Izake EL. Rapid and selective detection of recombinant human erythropoietin in human blood plasma by a sensitive optical sensor. Analyst 2021; 145:5508-5515. [PMID: 32598413 DOI: 10.1039/d0an00972e] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Recombinant human erythropoietin (rHuEPO) is an important hormone drug that is used to treat several medical conditions. It is also frequently abused by athletes as a performance enhancing agent at sporting events. The time window of the rHuEPO in blood is short. Therefore, the rapid detection of rHuEPO use/abuse at points of care and in sports requires a selective analytical method and a sensitive sensor. Herein, we present a highly selective method for the rapid detection of rHuEPO in human blood plasma by a sensitive optical sensor. rHuEPO is selectively extracted from human blood plasma by a target-specific extractor chip and converted into a biothiol by reducing its disulfide bond structure. The formed biothiol reacts with a water soluble (E)-1-((6-methoxybenzo[d]thiazole-2-yl)diazenyl)naphthalene-2,6-diolHg(ii) (BAN-Hg) optical sensor and causes its rapid decomposition. This leads to a rapid change in the sensor color from blue to pink that can be observed by the naked eye. The optical sensor was used to quantify rHuEPO in the concentration range 1 × 10-8 M to 1 × 10-12 M by UV-Vis spectroscopy. For the screening of blood plasma, an EPO-specific extractor chip was synthesized and used to selectively extract the protein from the biological matrix prior to its conversion into biothiol and quantification by the optical sensor. Since many proteins have a disulfide bond structure, the new method has strong potential for their rapid sensitive and selective detection by the BAN-Hg sensor and UV-Vis spectroscopy.
Collapse
Affiliation(s)
- Mahnaz D Gholami
- Queensland University of Technology (QUT), School of Chemistry and Physics, 2 George street QLD, 4000, Australia.
| | - Frederick Theiss
- Queensland University of Technology (QUT), School of Chemistry and Physics, 2 George street QLD, 4000, Australia.
| | - Prashant Sonar
- Queensland University of Technology (QUT), School of Chemistry and Physics, 2 George street QLD, 4000, Australia. and Centre for Material Science, Queensland University of Technology (QUT), 2 George street QLD, 4000, Australia
| | - Godwin A Ayoko
- Queensland University of Technology (QUT), School of Chemistry and Physics, 2 George street QLD, 4000, Australia. and Centre for Material Science, Queensland University of Technology (QUT), 2 George street QLD, 4000, Australia
| | - Emad L Izake
- Queensland University of Technology (QUT), School of Chemistry and Physics, 2 George street QLD, 4000, Australia. and Centre for Material Science, Queensland University of Technology (QUT), 2 George street QLD, 4000, Australia
| |
Collapse
|
5
|
Haynes AZ, Levine M. Detection of Human Growth Hormone (hGH) via Cyclodextrin-Promoted Fluorescence Modulation. ANAL LETT 2020. [DOI: 10.1080/00032719.2020.1828445] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- Anna Z. Haynes
- Department of Chemistry, University of Rhode Island, Kingston, RI, USA
| | - Mindy Levine
- Department of Chemical Sciences, Ariel University, Ariel, Israel
| |
Collapse
|
6
|
Kayser B, Tolleneer J. Ethics of a relaxed antidoping rule accompanied by harm-reduction measures. JOURNAL OF MEDICAL ETHICS 2017; 43:282-286. [PMID: 28154003 DOI: 10.1136/medethics-2015-102659] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/04/2016] [Revised: 12/08/2016] [Accepted: 01/10/2017] [Indexed: 06/06/2023]
Abstract
Harm-reduction approaches are used to reduce the burden of risky human behaviour without necessarily aiming to stop the behaviour. We discuss what an introduction of harm reduction for doping in sports would mean in parallel with a relaxation of the antidoping rule. We analyse what is ethically at stake in the following five levels: (1) What would it mean for the athlete (the self)? (2) How would it impact other athletes (the other)? (3) How would it affect the phenomenon of sport as a game and its fair play basis (the play)? (4) What would be the consequences for the spectator and the role of sports in society (the display)? and (5) What would it mean for what some consider as essential to being human (humanity)? For each level, we present arguments for and against doping and then discuss what a harm-reduction approach, within a dynamic regime of a partially relaxed antidoping rule, could imply. We find that a harm-reduction approach is morally defensible and potentially provides a viable escape out of the impasse resulting from the impossibility of attaining the eradication of doping. The following question remains to be answered: Would a more relaxed position, when combined with harm-reduction measures, indeed have less negative consequences for society than today's all-out antidoping efforts that aim for abstinence? We provide an outline of an alternative policy, allowing a cautious step-wise change to answer this question and then discuss the ethical aspects of such a policy change.
Collapse
Affiliation(s)
- Bengt Kayser
- ISSUL, Université de Lausanne, Lausanne, Switzerland
- FABER, Katholieke Universiteit Leuven, Leuven, Belgium
| | - Jan Tolleneer
- FABER, Katholieke Universiteit Leuven, Leuven, Belgium
| |
Collapse
|
7
|
Schönfelder M, Hofmann H, Schulz T, Engl T, Kemper D, Mayr B, Rautenberg C, Oberhoffer R, Thieme D. Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva. Drug Test Anal 2016; 8:1186-1196. [DOI: 10.1002/dta.2110] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2016] [Revised: 10/06/2016] [Accepted: 10/06/2016] [Indexed: 12/29/2022]
Affiliation(s)
- M. Schönfelder
- Chair of Exercise Biology; Technical University of Munich; Germany
- Institute of Pathology; Technical University of Munich; Germany
| | - H. Hofmann
- Chair of Preventive Pediatrics; Technical University of Munich; Germany
| | - T. Schulz
- Chair of Preventive Pediatrics; Technical University of Munich; Germany
| | - T. Engl
- Chair of Preventive Pediatrics; Technical University of Munich; Germany
| | - D. Kemper
- Chair of Preventive Pediatrics; Technical University of Munich; Germany
| | - B. Mayr
- Research Institute of Molecular Sports and Rehabilitation Medicine; Paracelus Medical Private University; Salzburg Austria
| | - C. Rautenberg
- Institute of Doping Analysis und Sports Biochemistry Dresden; Kreischa Germany
| | - R. Oberhoffer
- Chair of Preventive Pediatrics; Technical University of Munich; Germany
| | - D. Thieme
- Institute of Doping Analysis und Sports Biochemistry Dresden; Kreischa Germany
| |
Collapse
|
8
|
Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal 2014; 7:1-20. [DOI: 10.1002/dta.1769] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2014] [Accepted: 12/01/2014] [Indexed: 12/13/2022]
Affiliation(s)
- Mario Thevis
- Center for Preventive Doping Research - Institute of Biochemistry; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
- European Monitoring Center for Emerging Doping Agents; Cologne Germany
| | - Tiia Kuuranne
- Doping Control Laboratory; United Medix Laboratories; Höyläämötie 14 00380 Helsinki Finland
| | - Hans Geyer
- Center for Preventive Doping Research - Institute of Biochemistry; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| | - Wilhelm Schänzer
- Center for Preventive Doping Research - Institute of Biochemistry; German Sport University Cologne; Am Sportpark Müngersdorf 6 50933 Cologne Germany
| |
Collapse
|